Urological Devices – Market Insights – Europe

 Driven by the increasing prevalence of kidney diseases, aging population, product innovation, and patient awareness of urological treatments in this region, the European urological device market will continue to expand through 2032, despite the short-term negative impact of the COVID-19 pandemic. Furthermore, favorable demographic trends, an increasing prevalence of obesity, adoption of premium devices, and the growing availability of less invasive treatment options will support urological procedure volume growth. Moreover, the rising use of minimally invasive laser treatments in Europe, where these techniques have been underpenetrated, will result in increased adoption of associated devices.

This Medtech 360 Report provides comprehensive data and analysis on the of the market for urological devices in Europe from 2019 through 2032.

The COVID-19 pandemic had a short-term negative impact on the European urological device market.

At what pace are urological device market segments recovering?

Mergers and acquisitions have been altering the competitive landscape.

What are the most relevant recent acquisitions affecting the market?

How will market shares and product portfolios be affected as a result of these acquisitions?

Minimally invasive treatment volumes will increase in Europe over the forecast period.

How have minimally invasive treatment options changed the BPH device market?

Premium devices and their adoption will influence market trends.

Which markets are going to be affected by preference for premium variants of devices?

Internationally, a great deal of negative publicity has emerged surrounding the safety of synthetic mesh products.

How will this impact the genitourinary mesh market in Europe?

How physicians in the European market are reacting as compared to those in the US? 

Table of contents